-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 30, Hengrui Medicine issued an announcement stating that it had recently received the "Drug Registration Certificate" for propofol medium/long-chain fat emulsion injection approved and issued by the State Drug Administration
This product is a short-acting intravenous general anesthetic that can be used for: (1) the induction and maintenance of general anesthesia for adults and children over 1 month; (2) the diagnosis and operation of adults and children over 1 month.
Propofol medium/long-chain fat emulsion injection is a fast-acting short-acting general intravenous anesthetic.
Upon inquiry, the global sales of propofol-related dosage forms in 2020 are approximately US$1.